NDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Aug 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 24m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BETOPTIC (betaxolol hydrochloride) is a selective beta-1 adrenergic antagonist ophthalmic solution approved in 1985 for glaucoma and ocular hypertension management. It reduces intraocular pressure by decreasing aqueous humor production. The drug is administered as eye drops for topical ocular use.
LOE Approaching
As LOE approaches, expect reduced team size and shift toward legacy maintenance rather than growth-focused initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
Started Jan 2019
366 enrolled
Primary Open-angle GlaucomaOcular Hypertension
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
Started Jan 2003
105 enrolled
GlaucomaOcular Hypertension
Career Relevance
Working on BETOPTIC offers limited career advancement opportunities due to LOE-approaching status and zero linked job postings. Roles focus on defending market share and managing decline rather than driving growth or innovation.
Brand Manager (Legacy)
Worked on BETOPTIC at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.